TIGERMED News

Nomura Adjusts Hangzhou Tigermed Consulting's Price Target to HK$30.65 From HK$32.69, Keeps at Neutral

MT NewswiresJul 24 05:35 ET

Nomura Downgrades Tigermed to Neutral From Buy, Adjusts Price Target to 118.38 Yuan From 116.32 Yuan

MT NewswiresFeb 17, 2023 02:50 ET

Nomura Downgrades Tigermed to Neutral From Buy, Adjusts Price Target to HK$102.23 From HK$80.36

MT NewswiresFeb 17, 2023 02:43 ET

UBS Adjusts Hangzhou Tigermed Consulting's Price Target to HK$126.22 From HK$138.82, Keeps at Buy

MT NewswiresAug 30, 2022 05:36 ET

UBS Adjusts Hangzhou Tigermed Consulting's Price Target to 147.28 Yuan From 154.78 Yuan, Keeps at Buy

MT NewswiresAug 30, 2022 05:36 ET

Nomura Adjusts Tigermed’s Price Target to HK$105.58 From HK$108.33, Keeps at Buy

MT NewswiresAug 26, 2022 06:11 ET

Nomura Adjusts Tigermed’s Price Target to 122.78 Yuan From 119.66 Yuan, Nomura Keeps at Buy

MT NewswiresAug 26, 2022 06:11 ET

Nomura Adjusts Hangzhou Tigermed Consulting's Price Target to HK$108.33 From HK$115.13, Keeps at Buy

MT NewswiresAug 2, 2022 06:10 ET

Nomura Adjusts Hangzhou Tigermed Consulting's Price Target to 122.78 Yuan From 125.87 Yuan, Keeps at Buy

MT NewswiresAug 2, 2022 06:10 ET